NASDAQ Granted China SXT Pharmaceuticals, Inc. 180-Day Extension to Regain Compliance with Bid Price Requirement PR Newswire TAIZHOU, China...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
China SXT Pharmaceuticals, Inc. Announces That It Received a Grant Supported by City Government PR Newswire TAIZHOU, China, March 16, 2020...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G ...
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research...
China SXT Pharmaceuticals, Inc. Announced Regulatory Approval of Its DNA Exam Laboratory PR Newswire TAIZHOU, China, Jan. 16, 2020...
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency PR Newswire TAIZHOU, China, Jan. 3, 2020...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads